Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine doseWilliam A. Werbel, Dorry L. Segev, Sabra L. Klein et al.|American Journal of Transplantation|2023Cited by 19
Letter to the editor: “hook” (prozone) effect in sars‐cov‐2 anti‐spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant recipientsAura T. Abedon, William A. Werbel, Teresa Po‐Yu Chiang et al.|Clinical Transplantation|2023Cited by 1
Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipientsAndrew H. Karaba, William A. Werbel, Zoe Swank et al.|Transplant Infectious Disease|2024Cited by 1
Long-Term Safety of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant RecipientsX. Green, William A. Werbel, Chadi A. Hage et al.|American Journal of Transplantation|2025Cited by 0
Equivalent RSV Specific IgG and IgA Increases After Vaccination in Transplant RecipientsKatrin Gaardbo Kuhn, J Ronald Bailey, Jie Xue et al.|American Journal of Transplantation|2025Cited by 0